Source: Health Products and Food Branch (CA) Revision Year: 2020
TECTA – Pantoprazole enteric-coated tablets.
| Route of Administration | Dosage Form / Strength | Clinically Relevant Non-medicinal Ingredients |
|---|---|---|
| oral | Enteric-Coated Tablet 40 mg pantoprazole (as pantoprazole magnesium) | None For a complete listing see DOSAGE FORMS, COMPOSITION AND PACKAGING section. |
Note: As with all proton pump inhibitors, when TECTA (pantoprazole magnesium) is prescribed in combination with clarithromycin, amoxicillin or metronidazole for the eradication of an H. pylori infection, the Product Monograph for the antibiotics used should be consulted and followed.
TECTA (pantoprazole magnesium) is available as enteric-coated tablets for oral administration. The tablets are yellow, round, biconvex tablets marked 40 on one side and contain 40 mg pantoprazole. Tablets are available in bottles of 100 or 7 tablets, and in blisters of 7 and 30 tablets.
Not all pack sizes may be marketed.
Non-medicinal Ingredients: Anhydrous Sodium Carbonate, Mannitol, Crospovidone, Povidone, Calcium Stearate, Hypromellose, Titanium Dioxide, Ferric Oxide, Propylene Glycol, Poly (ethylacrylate, methacrylic acid), Triethyl Citrate.
| Marketing Informations | Authorization Dates |
|---|---|
|
Authorization holder:
Takeda Canada Inc., Toronto, Ontario, M5H 4E3 242002 |
Date of revision:
December 30, 2020 |
| Drug | Countries | |
|---|---|---|
| TECTA | Brazil, Canada, Ecuador, Hong Kong, Mexico |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
